|
|
Effect of Alteplase combined with Butylphthalide Injection in the treatment of acute cerebral infarction |
ZENG Hong-liang ZENG Xiang-jun |
Department of Neurology,the People′s Hospital of Ganzhou City,Jiangxi Province,Ganzhou 341000,China |
|
|
Abstract Objective To investigate the effect of Alteplase combined with Butylphthalide Injection in the treatment of acute cerebral infarction and its effect on hemorheology and neurological function.Methods Eighty patients with acute cerebral infarction admitted to our hospital from January 2016 to October 2017 were selected as objects and divided into the control group(40 cases)and the observation group(40 cases)according to the random number table method.The control group was treated with Alteplase Thrombolysis and the observation group was treated with Butylphthalide Injection on the basis of the control group.Hemorheological indicators,neurological factors of S-100 protein(S100B),myelin basic protein (MBP),and clinical efficacy before treatment and 7 d after treatment between two groups were compared.Results The plasma viscosity and platelet aggregation rate of two groups after treatment were lower than those before treatment,and the differences were statistically significant(P<0.05).The plasma viscosity and platelet aggregation rate in the observation group after treatment were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of S100B and MBP of two groups after treatment were lower than those before treatment,and the differences were statistically significant(P<0.05).The levels of S100B and MBP in the observation group after treatment were lower than those in the control group,and the differences were statistically significant(P<0.05).The total effective rate of the observation group was 92.50%,which was higher than that of the control group(75.00%),and the difference was statistically significant(P<0.05).Conclusion Alteplase combined with Butylphthalide Injection has significant effect on acute cerebral infarction,which can improve hemorrheology and neurological function,and is worth of promotion.
|
|
|
|
|
[1] |
刘东起.依达拉奉联合奥扎格雷钠治疗急性脑梗死的疗效及对血清CAT、MDA及SOD的影响[J].现代中西医结合杂志,2015,24(31):3481-3483.
|
[2] |
黄宁芳,杨桂钦,陈强.瑞舒伐他汀钙治疗老年脑梗死患者合并颈动脉粥样硬化斑块的疗效及对血脂、C反应蛋白水平的影响[J].中国老年学杂志,2017,37(6):1382-1383.
|
[3] |
张晓红,杜双霞,卢波.氯吡格雷联合阿司匹林双抗血小板治疗急性脑分水岭梗死的疗效观察[J].医学综述,2015,21(9):1718-1780.
|
[4] |
耿介立,俞羚,孙亚蒙,等.急性缺血性卒中患者早期处理指南:美国心脏协会/美国卒中协会的健康职业者指南[J].神经病学与神经康复学杂志,2013,10(1):33-80.
|
[5] |
全国第四届脑血管学术会议.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29(6):381-383.
|
[6] |
朱海霞,郝利霞,张琰.早期康复训练联合行为学疗法治疗老年脑卒中偏瘫患者的效果分析[J].安徽医药,2015,19(3):499-503.
|
[7] |
白丽虹,张燕如.丁苯酞注射液联合低分子肝素钙治疗进展性脑梗死的临床效果[J].中国老年学杂志,2016,36(10):2394-2396.
|
[8] |
林李.小剂量尿激酶联合低分子肝素治疗急性进展性脑梗死患者疗效及对神经功能的影响[J].中国实用神经疾病杂志,2016,19(24):71-73.
|
[9] |
姚峰.同剂量瑞舒伐他汀钙对老年冠心病伴高脂血症患者血清超敏C反应蛋白及颈动脉内膜中层厚度的影响[J].中国老年学杂志,2016,36(8):1842-1843.
|
[10] |
王东,张咏,潘金保,等.丁苯酞氯化钠注射液联合低分子肝素钙治疗急性进展性脑梗死的临床研究[J].卒中与神经疾病,2015,22(3):160-162.
|
[11] |
宋欣,蒋丽萍,李林萌,等.血浆 APTT、FIB、D-二聚体和hs-CRP检测在脑梗死患者中的临床意义[J].中国现代医生,2014,52(3):65-67.
|
[12] |
闫卫静.阿司匹林联合低分子肝素钙治疗进展性脑梗死的临床效果和安全性分析[J].实用心脑肺血管病杂志,2014,22(5):82-83.
|
[13] |
赖永坤,吕伟标,李锦荣.血清 S100B,MCP-1,COX-2 及hs-CRP与急性冠脉综合征的相关性分析[J].标记免疫分析与临床,2016,23(6):672-675.
|
[14] |
夏翠萍.急性脑梗死患者监测Ngb、BDNF和MBP的临床意义[J].临床误诊误治,2016,29(12):81-84.
|
[15] |
徐东升,张烨,王忠祥.颅脑损伤脑疝合并失血性休克的急诊救治与影响因素[J].中国当代医药,2017,24(25):26-28.
|
|
|
|